Benefits and risks of reinduction ipilimumab/nivolumab in patients with melanoma VJOncology 2:04 2 years ago 1 291 Скачать Далее
Benefits and risks of treatment with ipilimumab after complete resection of Stage III melanoma VJOncology 5:29 7 years ago 322 Скачать Далее
Dr. Luke Discusses the Controversy Surrounding Ipilimumab/Nivolumab Combo in Melanoma OncLive 1:57 7 years ago 2 476 Скачать Далее
Dr. Long on Nivolumab/Ipilimumab in Patients with Melanoma Brain Metastases OncLive 1:03 4 years ago 597 Скачать Далее
Adjuvant nivolumab in patents with high-risk resected melanoma VJOncology 2:22 2 years ago 279 Скачать Далее
Dr. Sharpless on Managing Toxicities With Nivolumab/Ipilimumab in Melanoma OncLive 1:34 8 years ago 1 054 Скачать Далее
Dr. Wolchok on Weighing Risk and Benefit of Nivolumab/Ipilimumab Combo in Melanoma OncLive 0:47 7 years ago 614 Скачать Далее
Melanoma patients who discontinued nivolumab and ipilimumab experienced equal or better PFS VJOncology 3:16 7 years ago 819 Скачать Далее
Ipilimumab Combined With Nivolumab for Patients With Melanoma Targeted Oncology 2:10 9 years ago 354 Скачать Далее
Combining nivolumab and ipilimumab in patients with resected stage IV melanoma VJOncology 2:54 1 year ago 293 Скачать Далее
Dr. Weber on the Toxicity Profile of Nivolumab Versus Ipilimumab for Melanoma OncLive 2:10 6 years ago 804 Скачать Далее
Dr. Atkins on Long-Term Survival Benefit of Nivolumab/Ipilimumab in Advanced Melanoma OncLive 2:35 4 years ago 3 631 Скачать Далее
New Long-term Data 'Clearly Favor' Combination Ipilimumab/Nivolumab in Melanoma Medscape 6:21 2 years ago 2 129 Скачать Далее
